Zika Virus Impact, Diagnosis, Control, and Models

<p>Section 1 – Methods, Biomarkers, and Diagnosis1. Imaging Zika virus infection2. Use of CRISPR: applications to flaviviruses3. Methods of investigating neurotoxicity of larvicides: applications of systems biology4. Methods for the detection of Zika virus infectivity</p> <p>Section 2 – Vector Control, Vaccines, Pharmacology 5. Vector control and Zika virus: a focus on mosquitoes6. Vector control: a focus on rural household containers: applications to Zika virus7. Zika virus Vaccines: an overview8. Novel treatment with 2,8-bis(trifluoromethyl)quinoline analogs in Zika infection in vitro9. Zika virus use of human neutralizing antibody in microcephaly prevention: a modelling system10. Policies on Zika virus Control</p> <p>Section 3 – Novel and Non-Pharmacologic Therapies11. Role of the pediatric neurologist in treating Zika virus syndrome12. 25-Hydroxycholesterol usage in Zika Virus Infection13. Screening and inhibition of the flavivirus NS2B-NS3 protease: application to zika virus14. Gene silencing and applications to zika virus15. Screening phytochemicals that react against Zika virus</p> <p>Section 4 – Models and Modelling16. Guinea pig model of Zika virus: features and applications17. Rat model of Zika virus: features and applications18. Mouse model of Zika virus: features and applications19. Modelling Zika virus in the USA20. Modelling Zika virus infection in laboratory animals: impact on neurological systems</p> <p>Section 5 – Neuroscience of Guillain-Barré Syndrome21. Severe Guillain-Barré Syndrome22. Plasmablasts, plasma and neurotoxic antibodies in Guillain-Barré syndrome23. Oxidative stress in Guillain-Barré Syndrome and linkage with neurology24. Neuromuscular effects and rehabilitation in Guillain-Barré syndrome25. Post-infectious demyelinating diseases: Guillain-Barré syndrome and beyond</p> <p>Section 6 – Neuroscience of Microcephaly26. Microcephaly and developmental delays27. Congenital microcephaly: features and risk factors28. Microcephaly in fetal alcohol syndrome29. Microcephaly in genetic disorders: the case of MFSD2A and hypomyelination30. Folate metabolism, 5,10-methenyltetrahydrofolate synthetase and microcephaly</p> <p>Section 7 – International Aspects31. Zika Virus in Honduras32. Zika Virus in Uganda33. Zika Virus in Jamaica34. Zika virus in Mozambique35. Zika virus in Brazil</p> <p>Section 8 – Case Reports36. Case reports: Zika and Chikungunya virus infection37. Case reports: Zika virus neuroretinitis38. Case reports: Zika virus infection in Singapore39. Case reports: Coinfection with Zika virus and dengue-2 viruses40. Case report: Guillain-Barré and Zika virus infection</p>